Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Hypertension × ganirelix × Clear all

Phase

Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 1 Hypertension 1

Interventions

pazopanib 1 ganirelix 1 benazepril 1 Ramipril 1 Preventive Health Services 1 Observation 1 Methyltestosterone 1 Losartan 1 Lisinopril 1 LHRH, Ac-Nal(1)-Cpa(2)-Trp(3)-Arg(6)-Ala(10)- 1 Fatty Acids, Omega-3 1 Desvenlafaxine Succinate 1 Bevacizumab 1 Adrenalectomy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04327934 2024-02-02

Mechanisms of Hypertension in Women With Polycystic Ovary Syndrome

Yale University

Phase EARLY_PHASE1 Terminated

28 enrolled 17 charts

Hypertension, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡